EUVIMEDSkopri EUVIMED
Crossref

Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy

Yuanying Zhang, Nan Yang, Ziyi Dong, Jiahui Wu, Rui Liao, Yanling Zhang, Gege Zhang, Mengfei Ren, Feng Wang iD, Xiaochen Dong iD, Pingping Liang

ACS Applied Materials & Interfaces · 2023

DOI: 10.1021/acsami.3c03471 ↗

At a glance

Journal article in ACS Applied Materials & Interfaces, 2023. Written by Yuanying Zhang and 10 co-authors. Institution: School of Life Sciences, Anhui Medical University, Hefei, Anhui 230032, China. Major MEDLINE topics: Nanoparticles, Photochemotherapy, Neoplasms, Nanostructures. Cited 14 times so far (Crossref); 45 references. Funded by: Anhui Medical University, National Natural Science Foundation of China, Natural Science Foundation of Anhui Province.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Avoiding the low specificity of phototheranostic reagents at the tumor site is a major challenge in cancer phototherapy. Meanwhile, angiogenesis in the tumor is not only the premise of tumor occurrence but also the basis of tumor growth, invasion, and metastasis, making it an ideal strategy for tumor therapy. Herein, biomimetic cancer cell membrane-coated nanodrugs (mBPP NPs) have been prepared by integrating (i) homotypic cancer cell membranes for evading immune cell phagocytosis to increase drug accumulation, (ii) protocatechuic acid for tumor vascular targeting along with chemotherapy effect, and (iii) near-infrared phototherapeutic agent diketopyrrolopyrrole derivative for photodynamic/photothermal synergetic therapy. The mBPP NPs exhibit high biocompatibility, superb phototoxicity, excellent antiangiogenic ability, and double-trigging cancer cell apoptosis in vitro. More significantly, mBPP NPs could specifically bind to tumor cells and vasculature after intravenous injection, inducing fluorescence and photothermal imaging-guided tumor ablation without recurrence and side effects in vivo. The biomimetic mBPP NPs could cause drug accumulation at the tumor site, inhibit tumor neovascularization, and improve phototherapy efficiency, providing a novel avenue for cancer treatment.

Subjects

MeSH terms (MEDLINE)

NanoparticlesPhotochemotherapyNeoplasmsNanostructuresHumansBiomimeticsPhototherapyCell Line, Tumor

Author keywords

antiangiogenic therapybiomimetic nanomaterialschemotherapyphototherapysynergistic therapy

Authors and institutions

  • School of Life Sciences, Anhui Medical University, Hefei, Anhui 230032, China.
  • Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing 211816, China.
  • CAS Key Laboratory of Soft Matter Chemistry, Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, China.
  • School of Chemistry & Materials Science, Jiangsu Normal University, Xuzhou 221116, China.

ORCID profiles: Feng Wang, Xiaochen Dong

Funding

  • Anhui Medical University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Anhui Province
  • Anhui Province Graduate Research Project

Cite

APA

Zhang, Y., Yang, N., Dong, Z., Wu, J., Liao, R., Zhang, Y., Zhang, G., Ren, M., Wang, F., Dong, X., & Liang, P. (2023). Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.3c03471

Vancouver

Zhang Y, Yang N, Dong Z, Wu J, Liao R, Zhang Y, et al. Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy. ACS Applied Materials & Interfaces. 2023. doi:10.1021/acsami.3c03471

BibTeX
@article{Zhang2023,
  author = {Zhang, Yuanying and Yang, Nan and Dong, Ziyi and Wu, Jiahui and Liao, Rui and Zhang, Yanling and Zhang, Gege and Ren, Mengfei and Wang, Feng and Dong, Xiaochen and Liang, Pingping},
  title = {Dual-Targeting Biomimetic Nanomaterials for Photo-/Chemo-/Antiangiogenic Synergistic Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2023},
  doi = {10.1021/acsami.3c03471}
}
Start for free →